Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Syncom Formulations (India) Limited (NSE: SYNCOMF), ISIN INE312C01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SYNCOMF last traded at ₹20.39 (+0.94%), with a 52-week range of ₹10.21 to ₹27.53 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 50.57%, FIIs 2.23%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 65/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.